Indication

Haemophilus influenzae bronchitis

*Haemophilus influenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucous membranes. Read more about Haemophilus influenzae bronchitis

202 drugs 81 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus influenzae bronchitis therapies.

Showing 163–171 of 202 drugs

CEFIXIME

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+8
REMEDYREPACK, I

CEFDINIR

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+15
DENTON PHARMA I
Filter & compare in the drug finder →Opens the drug finder with Haemophilus influenzae bronchitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus influenzae bronchitis.

*Haemophilus influenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucous membranes.

It primarily involves the tracheobronchial tree in adults and is frequently driven by nontypeable (unencapsulated) *H.

influenzae* strains, often presenting as an acute infection or an acute bacterial exacerbation of chronic bronchitis in individuals with underlying pulmonary disease such as chronic obstructive pulmonary disease (COPD) or bronchiectasis.

Pathophysiologically, the organism adheres to damaged respiratory epithelium and evades mucociliary clearance, resulting in mucosal inflammation, hypersecretion, persistent cough, purulent sputum production, and dyspnea.

Personalize your experience

Follow Haemophilus influenzae bronchitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it